Updates 2023 News Release

Press Releases Code Compliance Committee

Announcement Regarding the “JPMA Code of Practice: Month to Promote Understanding of the JPMA Code”

Press Releases

Three Pharmaceutical Associations from Japan, the U.S., and Europe
Joint Statement on the Proposal to Expand the Cost-Effectiveness Evaluation System

Press Releases Announcements

The Japan Pharmaceutical Manufacturers Association to Transition to a General Incorporated Association Effective October 1, 2026
— Turning Change and Challenges into Strength. Expanding the Circle of Co-creation. —

Announcements Event Reports

Public and Private Sectors Jointly Highlight the Evolution of the Japanese Market and Clinical Trial Environment at “BIO International Convention 2026”

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA’s 4th (FY2026) “Call for Proposals for Researcher Support and Grants”

Announcements Patient Cooperation Committee

We have posted the “Publicly Disclosed Information for FY 2025 Payments” from the “Transparency Guideline for Relationships Between Corporate Activities and Patient Organizations.”

Announcements Code Compliance Committee

We have posted the “Disclosed Information for Fiscal Year 2025 Payments” under the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions, etc.”

Announcements

We have posted the “Materials from the JPMA President’s Press Conference Held on July 30.”

Announcements Public Affairs Committee

We have published the “JPMA Newsletter, July 2026 Issue No. 230.”

Press Releases

Following the Cabinet’s Approval of the “Basic Policy 2026”

Press Releases

—Making Drug Discovery and Biotechnology Engines of Japan’s Growth— Following the Publication of the “Working Group Roadmap by the Japan Growth Strategy Council”

Press Releases Public Affairs Committee

Five JPMA Member Companies Participate in “Girls Meet STEM” — Each Company Hosts Its Own Program —

Press Releases

Top Leaders of Global Biopharmaceutical Companies Meet with Prime Minister Sanae Takaichi

Announcements Public Affairs Committee

We have published the “JPMA Newsletter, May 2026 Issue No. 229.”

Press Releases APAC Project

Following the “15th Asia Pharmaceutical Association Cooperation Conference (APAC)”

Press Releases APAC Project

Materials from the “15th Asia Pharmaceutical Associations Conference (APAC) Press Conference”

Press Releases Drug Evaluation Committee

“Don’t Blindly Believe Medical and Health Information!” Three Organizations Produce and Release Public Awareness Materials for the General Public

Announcements Code Compliance Committee

Revision of the Transparency Guideline for the Relation between Corporate Activities and Medical Institutions

Announcements

We have released the “Business Policy, Business Plan, and Implementation Plan” for Fiscal Year 2026.

Press Releases

Notice Regarding the Appointment of New Officers

Announcements

“DATA BOOK 2026” has been published.

Announcements

We have posted the "Materials from the JPMA President's Press Conference Held on February 19."

Press Releases Pharmaceutical Industrial Policy Committee

Regarding “Recommendations on Intractable and Rare Diseases Based on a Survey of Healthcare Professionals’ Challenges”

Announcements Public Affairs Committee

JPMA Newsletter No. 228

Announcements

New Year’s Greetings

Press Releases

In Response to the FY2026 (Reiwa 8) Drug Pricing System Reform and Cost-Effectiveness Evaluation System Reform

Press Releases

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Opinions on the FY2026 (Reiwa 8) Drug Price System Reform and Cost-Effectiveness Evaluation System Reform

Press Releases Drug Evaluation Committee

Regarding the Release of the Joint Statement “Clinical Trial Ecosystem Industry Declaration 2025”

Announcements International Affairs Committee

Announcement Posted Regarding the Webinar “Toward the Formation of a Global Community to Promote Antimicrobial R&D.”

Press Releases Public Affairs Committee

Third Place Awarded in the “My CareerStudy Course Contest 2025.” JPMA’s video course for undergraduate students received high praise from student judges.

Announcements Public Affairs Committee

"JPMA Newsletter No. 227" has been published.

Announcements

We have posted interview articles with the Chairpersons of the " Toward Realizing the JPMA's Vision for 2035."

Press Releases

On the Inauguration of New Prime Minister Sanae Takaichi

Press Releases Code Compliance Committee

Announcement Regarding the “JPMA Code of Practice: Month to Promote Understanding of the JPMA Code”

News Release

Participation in the “Kusuri Visionary Conference 2025”
Expanding the Circle of Stakeholders and Engaging in Discussions Toward Co-Creation

Announcements

We have published an article titled “My Theory of Leadership” in the Nikkei Shimbun.

Announcements Code Compliance Committee

Publication of the Book “JPMA Code of Practice (Revised May 2025)”

Announcements R & D Committee

We have published “Scientific and Practical Requirements for Drug Candidate Substances Sought by Companies: Regarding the Description of the Target Product Profile (TPP).”

Press Releases

Notice Regarding the Appointment of New Officers

Press Releases Public Affairs Committee

[For Elementary School Students and Their Parents] Perfect for the Fall Holiday Break! Hands-on Event at the National Museum of Science and Technology. “JPMA Kusurium Lab 2025 Fall”—a fun way to learn about medicines. A social media campaign offering free admission is currently underway.

Announcements Public Affairs Committee

We have posted “Science and Technology Museum ‘JPMA Kusurium Lab 2025 Fall’ Invitation Campaign!”

Announcements Public Affairs Committee

We have published “Understanding the Pharmaceutical Industry Through Manga: ‘Open Up! The World of Medicines Connecting to the Future.’”

Announcements

We have posted the “Newspaper Advertisement.”

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA’s 3rd (FY 2025) “Open Call for Researcher Support and Grants”

Announcements Patient Cooperation Committee

We have updated the “Disclosed Information for FY 2024 Payments” in the “Transparency Guideline for Relationships Between Corporate Activities and Patient Organizations.”

Announcements Code Compliance Committee

We have updated the “Disclosed Information for Fiscal Year 2024 Payments” under the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions, etc.”

Announcements

We have published JPMA’s Vision for 2035 (English Version.)

Announcements

We have published JPMA’s Vision for 2035 (English Version.)

Press Releases Public Affairs Committee

JPMA Sponsors the Sendenkaigi Award (Junior High and High School Student Division) — Creating a Future for Life Together with the Young Generation Who Will Shape Tomorrow —

Announcements Public Affairs Committee

“JPMA Newsletter No. 226” has been published.

Press Releases Environmental Issue Committee

Selected for the Ministry of the Environment’s “Model Project to Promote Decarbonization Across the Entire Value Chain” — 12 Companies Participate to Develop Common CO2 Emissions Calculation Rules for the Pharmaceutical Industry

Press Releases

Following the Cabinet’s Approval of the “Basic Policy 2025”

Announcements

We have posted the presentation video from the “Press Conference by the President of the JPMA, Held on May 22.”

Press Releases Code Compliance Committee

Regarding the Revision of the JPMA Code of Practice

Announcements Public Affairs Committee

We have posted the “JPMA Guide 2025.”

Announcements

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on May 22.”

Press Releases

Notice Regarding the Appointment of New Officers

Announcements

We have updated the “Newspaper and Digital Advertising” section.

Announcements Public Affairs Committee

"JPMA Newsletter No. 225" has been published.

Announcements

We have updated the “Newspaper and Digital Advertising” section.

Press Releases APAC Project

Following the “14th Asia Pharmaceutical Associations Cooperation Conference (APAC)”

Press Releases APAC Project

“Materials from the Press Conference on the 14th Asia Pharmaceutical Association Cooperation Conference (APAC), Held on April 23” have been posted.

Announcements

We have published the “Business Policy, Business Plan, and Implementation Plan” for Fiscal Year 2025.

Announcements Event Reports

We have posted a report on the “Press Conference by the Chairman of the JPMA.”

Announcements Code Compliance Committee

We have updated the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions”

Announcements

We have released “DATA BOOK 2025.”

Announcements

We have posted the presentation video from the “Press Conference by the President of the JPMA held on February 26.”

Announcements

"Materials from the JPMA Chairman’s Press Conference Held on February 26" have been posted.

Press Releases

Regarding JPMA’s Vision for 2035 and JPMA’s Policy Proposals for 2025

Press Releases Public Affairs Committee

Regarding the “18th Survey on Public Perceptions of Medicines and the Pharmaceutical Industry”

Press Releases Public Affairs Committee

[For Elementary School Students and Their Parents] Aim to Become a Medication Researcher This Spring Break! Announcement of the “JPMA Kusurium Lab,” a Hands-On Event Where You Can Learn All About Medications

Announcements Public Affairs Committee

We have published the “Textbook: Pharmaceutical Industry 2024–2025.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 224” has been published.

Announcements Distribution Improvement Committee

We have updated the “FAQ Regarding Changes to the Industry Standard Manual ‘EDI Unified Data Format’ and the 8th System Upgrade of JD-NET.”

Press Releases Drug Evaluation Committee

Announcement Regarding the Release of an Awareness Video on the Utilization of Health and Medical Data

Announcements APAC Project

A new “APAC Project” section has been added to the Committees page.

Announcements

We have posted the “2025 New Year’s Greeting from the President of the JPMA.”

Press Releases

Regarding the FY2025 (Reiwa 7) Drug Price Revision

Press Releases

We have posted “Participation in the ‘Pharmaceutical Visionary Conference 2024’
Aiming for Dialogue and Co-creation Among Diverse Stakeholders.”

Announcements

We have posted the “Announcements and Key Q&A” from the Chairman’s press conference.

Announcements Public Affairs Committee

We have posted the booklet “Detective Medizon and the Six Mysteries (2nd Edition).”

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the “Survey on Challenges Faced by Healthcare Professionals in the Field of Rare Diseases”

Announcements Public Affairs Committee

A new “Public Affairs Committee” section has been added to the Committees page.

Press Releases Code Compliance Committee

Announcement Regarding the “Code of Practice Understanding Promotion Month” for the JPMA

Announcements Consumer Consultation Review Committee

A new “Consumer Consultation Review Committee” has been added to the Committees page.We have posted the presentation video from the “October 8 Pharmaceutical Association Chairman’s Press Conference.”

Announcements

We have posted the presentation video from the “Press Conference by the President of the JPMA Held on October 8.”

Announcements

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on October 8.”

Announcements Public Affairs Committee

We have posted the “FY2024 JPMA PR and Communications Plan.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 223” has been published.

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA’s 2nd (FY 2024) “Open Call for Researcher Support and Grants”

Announcements Public Affairs Committee

“JPMA Newsletter No. 222” has been published.

Press Releases

Regarding “Initiatives to Eliminate Drug Loss,” as proposed at the Ministry of Health, Labor and Welfare’s Council for the Review of Unapproved Drugs and Off-Label Drugs with High Medical Need

Announcements Code Compliance Committee

We have updated the “Publicly Disclosed Information for FY2023 Payments” in the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions”

Announcements Public Affairs Committee

We have posted the “JPMA Guide 2024.”

Announcements Public Affairs Committee

"JPMA Newsletter No. 221" has been published.

Press Releases APAC Project

Following the “13th Asia Pharmaceutical Association Cooperation Conference”

Press Releases APAC Project

Press Conference Materials for the 13th Asia Pharmaceutical Association Cooperation Conference (APAC)

Announcements Drug Evaluation Committee

We have posted the “Glossary of Health and Medical Data Terms.”

Announcements R & D Committee

"R & D Needs of Research Committee Member Companies" has been posted.

Announcements

We have published the “FY2024 Business Policy, Business Plan, and Implementation Plan.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 220” has been published.

Press Releases Public Affairs Committee

The second installment of the awareness-raising event in the pharmaceutical and healthcare sectors, “Living with Illness. Living with Hope. Photo Exhibition—Toward a Future That Creates Answers We Have Yet to See,” was held in Osaka

Announcements

We published a newspaper advertisement titled “Let’s Think About Rare Diseases—Toward a More Understanding Society.”

Announcements

We have released “DATA BOOK 2024.”

Announcements

We have posted the presentation video from the “Press Conference by the Chairman of the JPMA held on February 15.”

Press Releases

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on February 15.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 219” has been published.

Announcements

Regarding the Reiwa 6 Noto Peninsula Earthquake

Announcements

"New Year’s Greetings for 2024 from the Chairman of the JPMA" has been posted.

Announcements

We have posted the “Newspaper Advertisement.”

Press Releases Public Affairs Committee

Regarding the “17th Survey on Consumer Perceptions of Medicines and the Pharmaceutical Industry”

Press Releases

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Joint Statement on the FY2024 (Reiwa 6) Drug Pricing System Reform and Cost-Effectiveness Evaluation System Reform

Press Releases Public Affairs Committee

Public Awareness Event in the Pharmaceutical and Medical Fields: “Living with Illness. Living with Hope. Photo Exhibition: Toward a Future That Creates Answers We Have Yet to See”

Announcements Public Affairs Committee

“JPMA Newsletter No. 218” has been published.

Announcements Distribution Improvement Committee

The “Industry Standard Manual” has been updated.

Press Releases Code Compliance Committee

Announcement Regarding the “Code of Practice Understanding Promotion Month” for the JPMA

Announcements Code Compliance Committee

The “Consensus Framework for Ethical Collaboration in Japan” initiative received the “2023 The Lighthouse Award.”

Announcements Review Board of Ethical Drug Product Information Brochure

The revised version of the “Guidelines for Preparing Summaries of Product Characteristics for Prescription Drugs” has been posted.

Announcements Public Affairs Committee

“JPMA Newsletter No. 217” has been published.

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA “Open Call for Researcher Support and Grants”

Announcements Distribution Improvement Committee

We have posted the “FAQ on Changes to the Unified EDI Data Format.”

Announcements Distribution Improvement Committee

The “Industry Standard Manual” has been updated.

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA’s “Proposals on Intractable and Rare Diseases”

Announcements Public Affairs Committee

“JPMA Newsletter No. 216” has been published.

Press Releases

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe Regarding the “Draft Report of the Expert Panel on Comprehensive Measures to Ensure the Rapid and Stable Supply of Pharmaceuticals”

Announcements

We have posted the presentation video from the “Press Conference by the President of the JPMA Held on May 25.”

Announcements Public Affairs Committee

We have posted the “JPMA Guide 2023.”

Press Releases

Notice Regarding the Appointment of New Officers

Announcements Public Affairs Committee

"JPMA Newsletter No. 215" has been published.

Announcements

“Newspaper Ads” and “Digital Ads” have been posted.

Press Releases

We have posted “Revision of the Classification of COVID-19 Under the Infectious Diseases Control Law.”

Press Releases Drug Evaluation Committee

We have posted “Announcement Regarding the Release of ‘Health and Medical Data and Our Lives,’ an Educational Brochure for the General Public on the Use of Health and Medical Data.”

Announcements Drug Evaluation Committee

We have posted “Health and Medical Data and Our Lives.”

Announcements Code Compliance Committee

We have revised the “JPMA Compliance Program Guidelines.”

Press Releases Pharmaceutical Industrial Policy Committee

We have posted “Research and Recommendations on the Pharmaceutical Industry’s Contribution to Extending Healthy Life Expectancy and Driving Economic Growth: Toward the Future of the Pharmaceutical Industry.”

Press Releases APAC Project

“Reflections on the ‘12th Asia Pharmaceutical Association Cooperation Conference’” has been posted.

Press Releases APAC Project

“Press Conference Materials for the 12th Asia Pharmaceutical Association Cooperation Conference (APAC), Held on April 19” has been posted.

Press Releases

We have posted the joint statement by the three pharmaceutical associations of Japan, the U.S., and Europe titled “Proposals for the FY2024 (Reiwa 6) Drug Pricing System Reform.”

Announcements

We have released the “FY2023 Business Policy, Business Plan, and Implementation Plan.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 214” has been published.

Announcements

“DATA BOOK 2023” has been published.

Announcements

We have posted the “Presentation Video from the JPMA President’s Press Conference Held on February 16.”

Announcements

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on February 16.”

Press Releases

We have posted the “JPMA Policy Proposals 2023.”

Press Releases Pharmaceutical Industrial Policy Committee

Regarding the JPMA’s “Survey on the Challenges Faced by Patients with Rare Diseases”

Announcements

We have posted the “Newspaper Advertisement.”

Announcements

We have posted the “Newspaper Advertisement.”

Announcements Environmental Issue Committee

We have established a new “Environmental Issue Committee.”

Announcements Public Affairs Committee

"JPMA Newsletter No. 213" has been published.

Announcements

We have posted the “2023 New Year’s Greetings from the President of the JPMA.”

Announcements Pharmaceutical Industrial Policy Committee Public Affairs Committee

We have posted the PIVOT tie-in video “& questions | What Is the Innovation That Will Change Japan?”

Press Releases

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Regarding the FY2023 (Reiwa 5) Drug Price Revision

Announcements Public Affairs Committee

We have published the “Textbook of the Pharmaceutical Industry 2022–2023.”

Press Releases Public Affairs Committee

Regarding the “16th Survey on Consumer Attitudes Toward Medicines and the Pharmaceutical Industry”

Press Releases

We have posted the “Joint Opinion on the Mid-Year Drug Price Revision” by three pharmaceutical associations from Japan, the U.S., and Europe.

Announcements

We have published “Opinion on Access to Digital Sequence Information and Profit Sharing.”

Announcements Public Affairs Committee

“JPMA Newsletter No. 212” has been published.

Press Releases

Following the Cabinet’s approval of the “Second Supplementary Budget Bill for Fiscal Year Reiwa 4,”

Press Releases International Affairs Committee

Proposals from the Pharmaceutical Industry for the G7 Hiroshima Summit Health Agenda:

Announcements

Following the Cabinet’s approval of the “Comprehensive Economic Measures to Overcome Rising Prices and Achieve Economic Recovery”—Statement by the President of the JPMA has been posted.

Press Releases Code Compliance Committee

We have posted a “Notice Regarding the JPMA Code of Practice ‘Code Awareness Month.’”

Press Releases

“Collaboration Between the University of Tokyo, Tokyo Medical and Dental University, and the JPMA at the Greater Tokyo Biocommunity (GTB) Hongo, Ochanomizu, and Tokyo Station Area Hub” has been posted.

Press Releases

"Appointment of New Executive Officers" has been posted.

Announcements Public Affairs Committee

“JPMA Newsletter No. 211” has been published.

Announcements

We have posted the “Video of the Presentation from the JPMA President’s Press Conference Held on August 30.”

Announcements

"Materials from the JPMA President's Press Conference Held on August 30" have been posted.

Announcements Pharmaceutical Industrial Policy Committee

We have posted the presentation materials from the “JPMA Media Forum (held July 19, 2022).”

Announcements Public Affairs Committee

"JPMA Newsletter No. 210" has been published.

Press Releases

Toward Building an Ecosystem to Enhance Japan’s Drug Discovery Capabilities

Announcements

An interview article with the President of the JPMA, “The Vision I Seek for Japan Now That We Have Experienced COVID-19,” has been posted in the “Magazine” category.

Press Releases Intellectual Property Committee

Regarding the Agreement on Exemptions from Intellectual Property Protection Obligations (TRIPS Waiver) at the 12th WTO Ministerial Conference

Press Releases Pharmaceutical Industrial Policy Committee

Jointly produced and released by the Council for the Proper Use of Medicines and the Japan Pharmaceutical Manufacturers Association: An educational video on polypharmacy titled “How Many Medications Are You Taking?”

Press Releases

We have published the “Statement by the R&D-Based Pharmaceutical Industry on the Discussions Scheduled for the 12th WTO Ministerial Conference Regarding Exemptions from Intellectual Property Protection Obligations.”

Announcements Public Affairs Committee

We have published the “JPMA Guide 2022.”

Announcements Patient Cooperation Committee

We have updated the section “About the Transparency Guideline” in the Guidelines on Transparency in Relations Between Corporate Activities and Patient Organizations.

Announcements Public Affairs Committee

We have published “JPMA Newsletter No. 209.”

Press Releases

We have posted “Proposal by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Joint Proposal for the Formulation of the ‘Basic Policy’ and ‘Growth Strategy’.”

Announcements

We have posted the “Newspaper Advertisement.”

Announcements

“Digital Advertising” has been posted.

Press Releases

Regarding Discussions on Exemptions from Intellectual Property Protection Obligations at the WTO

Press Releases APAC Project

We have posted “Press Conference Materials for the 11th Asia Pharmaceutical Industry Association Conference (APAC) Held on April 6.”

Press Releases APAC Project

We have published “Reflections on the ‘11th Asia Pharmaceutical Industry Association Conference’.”

Announcements

We have released the “FY2022 Business Policy, Business Plan, and Implementation Plan.”

Announcements

We have posted the “Newspaper Advertisement.”

Press Releases Drug Evaluation Committee

“Three Organizations Related to Clinical Trials Jointly Formulate ‘Data Integrity Declaration’” has been posted.

Announcements Code Compliance Committee

We have posted the “Transparency Guideline: English Version (Revised January 20, 2022).”

Announcements

“DATA BOOK 2022 (English)” has been published.

Announcements Public Affairs Committee

We have published “JPMA Newsletter No. 208.”

Announcements Public Affairs Committee

We have released “YELL for New Drugs,” a collaboration with Tokyo Graffiti.

Announcements Public Affairs Committee

We have released videos #5–#8 of “Learning About New Drug Innovation with Pharmacy Student Aoi.”

Announcements

We have published “DATA BOOK 2022 (Japanese).”

Press Releases

Joint Statement Released: “Three Priorities for Urgently Increasing Access to COVID-19 Vaccines”

Announcements

“JPMA Video Content” has been updated.

Press Releases Public Affairs Committee

FY2021 JPMA Communication Plan

Announcements Code Compliance Committee

We have posted the “Transparency Guideline (Revised January 20, 2022).”

Announcements Public Affairs Committee

We have posted an “Announcement Regarding the Launch of the JPMA Official Twitter Account.”

Announcements Public Affairs Committee

Videos #1–#4 of “Learning About New Drug Innovation with Pharmacy Student Aoi” have been released.

Announcements

“Materials from the JPMA Chairman’s Press Conference Held on January 20” have been posted.

Announcements Public Affairs Committee

“JPMA Newsletter No. 207” has been published.

Announcements

New Year’s Greeting from the President of JPMA, 2022

Press Releases

Reiwa 4 Pharmaceutical Price System Reform

Announcements Public Affairs Committee

We have posted the Asahi Shimbun’s “Job Yearbook 2021.”

Press Releases Public Affairs Committee

"Regarding the 15th Consumer Awareness Survey on Medicines and the Pharmaceutical Industry"

Announcements Public Affairs Committee

"The 15th Survey on Consumer Awareness of Medicines and the Pharmaceutical Industry" has been published.

Announcements Public Affairs Committee

“JPMA Newsletter No. 206” has been published.

Press Releases Code Compliance Committee

We have posted a “Notice Regarding the JPMA Code of Practice ‘Code Awareness Month.’”

Press Releases

A new “List of Non-Financial Information Disclosures” (Link Collection) for JPMA Member Companies has been added

Announcements

We have posted the “Newspaper Advertisement.”

Announcements ICH Project

Information on the “ICH Quality Forum” has been posted.

Announcements Public Affairs Committee

“JPMA Newsletter No. 205” has been published.

Press Releases

Following the announcement of the “Pharmaceutical Industry Vision 2021,”

Press Releases

The JPMA website has been redesigned.

Announcements International Affairs Committee Public Affairs Committee

The “JPMA Guide 2021 (English and Chinese Editions)” has been posted.

Announcements International Affairs Committee

We have updated the “IFPMA Vaccines Confidence Digital Campaign.”

Press Releases

Regarding Disciplinary Actions Against Member Companies

Announcements Public Affairs Committee

We have published “JPMA Newsletter No. 204.”

Announcements Drug Evaluation Committee

We have posted the “YouTube Video: Innovative Changes in Data Management.”

Announcements Public Affairs Committee

"JPMA Guide 2021" has been posted.

Press Releases

“Materials from the JPMA Chairman’s Press Conference Held on May 20” have been posted.

Announcements

We have updated the “President’s Greeting” and “List of Officers.”

Announcements

Notice Regarding the Appointment of New Officers

Press Releases

Regarding the “JPMA Industry Vision 2025: Supplement”

Announcements Public Affairs Committee

"JPMA Newsletter No. 203" has been published.

Press Releases

Regarding the Waiver of Intellectual Property Rights at the WTO

Announcements

We have posted the “Newspaper Advertisement.”

Press Releases APAC Project

Following the “10th Asia Pharmaceutical Association Collaboration Conference”

Announcements

The FY2021 “Business Policy, Business Plan, and Implementation Plan” has been published.

Announcements

“DATA BOOK 2021 (English Edition)” has been published.

Announcements Public Affairs Committee

"Textbook: Pharmaceutical Industry 2020–2021" has been published.

Announcements

We have posted the materials from the “Press Conference by the Chairman of the JPMA.”

Announcements

We have published the “JPMA Policy Proposals 2021.”

Announcements

We have published the “DATA BOOK 2021 (Japanese Version).”

Announcements Public Affairs Committee

"JPMA Newsletter No. 202" has been published.

Announcements Drug Evaluation Committee

We have posted the 5th edition of “Medicines and Clinical Trials.”

Press Releases R & D Committee

We have posted “National Center Biobank Network and Japan Pharmaceutical Manufacturers Association Member Companies Launch Industry-Academia-Government Collaboration on the Construction and Utilization of an Integrated Disease-Specific Database—Toward the Early Implementation of Precision Medicine, Prevention, and Proactive Healthcare.”

Announcements Public Affairs Committee

We have published “JPMA Newsletter No. 201.”

Press Releases

Initiatives to Combat the Novel Coronavirus – In Response to the Declaration of a State of Emergency –